0001213900-22-001441.txt : 20220110
0001213900-22-001441.hdr.sgml : 20220110
20220110215003
ACCESSION NUMBER: 0001213900-22-001441
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220110
DATE AS OF CHANGE: 20220110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Radoff Bradley Louis
CENTRAL INDEX KEY: 0001380585
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09974
FILM NUMBER: 22522619
MAIL ADDRESS:
STREET 1: 1177 WEST LOOP SOUTH
STREET 2: SUITE 1625
CITY: HOUSTON
STATE: TX
ZIP: 77027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENZO BIOCHEM INC
CENTRAL INDEX KEY: 0000316253
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 132866202
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
BUSINESS PHONE: 5167555500
MAIL ADDRESS:
STREET 1: ENZO BIOCHEM INC
STREET 2: 60 EXECUTIVE BLVD
CITY: FARMINGDALE
STATE: NY
ZIP: 11735
3
1
ownership.xml
X0206
3
2022-01-03
0
0000316253
ENZO BIOCHEM INC
ENZ
0001380585
Radoff Bradley Louis
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE
NEW YORK
NY
10022
1
0
0
0
Common Stock
3898100
D
Common Stock
400000
I
By The Radoff Family Foundation
The shares of Common Stock are directly held by The Radoff Family Foundation (the "Radoff Foundation"). Mr. Radoff is a director of the Radoff Foundation and may be deemed to beneficially own the shares of Common Stock held by the Radoff Foundation. Mr. Radoff disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Bradley L. Radoff
2022-01-10